Literature DB >> 16922497

Recognition of B-DNA by neomycin--Hoechst 33258 conjugates.

Bert Willis1, Dev P Arya.   

Abstract

Recent developments have indicated that aminoglycoside binding is limited not to RNA but to nucleic acids that, like RNA, adopt conformations similar to the A-form. We have further sought to expand the utility of aminoglycoside binding to B-DNA structures by conjugating neomycin, an aminoglycoside antibiotic, with the B-DNA minor groove binding ligand Hoechst 33258. Described herein are novel neomycin-Hoechst 33258 conjugates developed for exploring B-DNA groove recognition. We have varied the two reported conjugates in linker length and composition in an effort to improve our understanding of the spatial differences that define B-DNA binding. Spectroscopic studies such as ultraviolet (UV) melting, isothermal fluorescence titrations, differential scanning calorimetry (DSC), and circular dichroism (CD) together illustrate the mode of binding by such conjugates. Both conjugates exhibit enhanced thermal stabilization of A.T rich duplexes when compared to Hoechst 33258.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16922497     DOI: 10.1021/bi0609265

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Click dimers to target HIV TAR RNA conformation.

Authors:  Sunil Kumar; Patrick Kellish; W Edward Robinson; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Biochemistry       Date:  2012-03-09       Impact factor: 3.162

2.  Microarray detection of duplex and triplex DNA binders with DNA-modified gold nanoparticles.

Authors:  Abigail K R Lytton-Jean; Min Su Han; Chad A Mirkin
Journal:  Anal Chem       Date:  2007-07-06       Impact factor: 6.986

3.  Utilization of chromic polydiacetylene assemblies as a platform to probe specific binding between drug and RNA.

Authors:  Anothai Kamphan; Changjun Gong; Krishnagopal Maiti; Souvik Sur; Rakchart Traiphol; Dev P Arya
Journal:  RSC Adv       Date:  2017-08-24       Impact factor: 3.361

4.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

Review 5.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

6.  Linker dependent intercalation of bisbenzimidazole-aminosugars in an RNA duplex; selectivity in RNA vs. DNA binding.

Authors:  Nihar Ranjan; Dev P Arya
Journal:  Bioorg Med Chem Lett       Date:  2016-10-27       Impact factor: 2.823

7.  New Application of Neomycin B-Bisbenzimidazole Hybrids as Antifungal Agents.

Authors:  Nishad Thamban Chandrika; Sanjib K Shrestha; Nihar Ranjan; Anindra Sharma; Dev P Arya; Sylvie Garneau-Tsodikova
Journal:  ACS Infect Dis       Date:  2017-12-11       Impact factor: 5.084

8.  Influence of linker length in shape recognition of B* DNA by dimeric aminoglycosides.

Authors:  Sunil Kumar; Meredith Newby Spano; Dev P Arya
Journal:  Bioorg Med Chem       Date:  2015-05-08       Impact factor: 3.641

9.  Shape readout of AT-rich DNA by carbohydrates.

Authors:  Sunil Kumar; Meredith Newby Spano; Dev P Arya
Journal:  Biopolymers       Date:  2014-07       Impact factor: 2.505

10.  Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.

Authors:  Nihar Ranjan; Geraldine Fulcrand; Ada King; Joseph Brown; Xiuping Jiang; Fenfei Leng; Dev P Arya
Journal:  Medchemcomm       Date:  2014-06-01       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.